Interestingly, we have observed that downregulation of miRNA-125b or overexpression of protein targets of miR-497 could be used as a biomarker for early relapse in human ALK(+) ALCL primary biopsies [62,63]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.